Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
AUC |
32.8 |
ng.h/ml |
90.63 |
nmol.h/L |
PO, oral; |
DRUGBANK |
AUC |
72.2 |
ng.h/ml |
199.1 |
nmol.h/L |
PO, oral; |
DRUGBANK |
AUC |
1163.0 |
ng.h/ml |
1163±277 |
ng.h/ml |
intravenous injection, IV; |
DRUGBANK |
Bioavailability |
11.5 |
% |
4-19 |
% |
skin/dermal; |
DRUGBANK |
Bioavailability |
50.2 |
% |
50.2 |
% |
Rectal Administration; immediate release formulation; |
DRUGBANK |
Bioavailability |
81.0 |
% |
81 |
% |
Rectal Administration; extended release formulation; |
DRUGBANK |
C Max |
11.8 |
ng/ml |
32.69 |
nmol/L |
PO, oral; |
DRUGBANK |
C Max |
25.7 |
ng/ml |
70.81 |
nmol/L |
PO, oral; |
DRUGBANK |
T Max |
24.0 |
h |
24 |
h |
skin/dermal; |
DRUGBANK |
Clearance |
12.9 |
L/h |
12.85 |
L/h |
Average clearance; PO, oral; |
DRUGBANK |
Clearance |
18.2 |
L/h |
18.2±4.2 |
L/h |
intravenous injection, IV; |
DRUGBANK |
Clearance |
0.34 |
L/h/kg |
5.7 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
39.8 |
L |
39.82 |
L |
Total volume of distribution; |
DRUGBANK |
Volume of Distribution |
474.4 |
L |
474.38 |
L |
Total volume of distribution; |
DRUGBANK |
Volume of Distribution |
0.38 |
L/kg |
0.38 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
2.2 |
h |
2.15 |
h |
PO, oral; |
DRUGBANK |
Half-life |
1.4 |
h |
1.39 |
h |
|
DRUGBANK |
Half-life |
1.9 |
h |
1.9±0.4 |
h |
terminal half-life; intravenous injection, IV; |
DRUGBANK |
Half-life |
1.6 |
h |
1.6 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Protein Binding |
90.1 |
% |
90.1 |
% |
plasma proteins; |
DRUGBANK |
Protein Binding |
56.2 |
% |
56.2 |
% |
|
DRUGBANK |